Krebs Biochemicals & Industries Ltd.
KREBSBIO Share PricePharmaceuticals & Drugs
₹65.28
0.7 (1.1%)
As on December 4, 2025
Exchange Scrips: BSE524518NSEKREBSBIOISININE268B01013
Market Cap ₹ 138 Cr
P/E Ratio -5.22
Dividend Yield N/A
Performance
Market performance
Open65.5
High66.56
Volumes5,703
Prev65.28
Low63.6
As on2025-12-04
Historical performance
1 Year High115.8
3 Year High129.07
5 Year High227.9
1 Year Low63.6
3 Year Low50.65
5 Year Low50.65
Fundamentals
Company Valuation
Market Cap (₹Cr)
138
Face Value (₹)
10
P/E Ratio
-5.22
Dividend Yield
N/A
Investment Returns
1 Year
-38%
3 Years
-43.5%
5 Years
-34.5%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 65.49 | Bearish |
| 10-DMA | 65.52 | Bearish |
| 20-DMA | 66.62 | Bearish |
| 50-DMA | 69.17 | Bearish |
| 100-DMA | 73.11 | Bearish |
| 200-DMA | 76.6 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 8906 | 9112 | 8792 | 9085 | 9419 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -5.22.
- 3Y Stock Price CAGR of the stock is -16.5.
- The stock has a beta of 1.3.
- In the last financial year, the company had an EBITDA of ₹-143 Million.
- The company generated revenue of ₹433 Million in the previous financial year.
Krebs Biochemicals & Industries Ltd.
65.280.7 (1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 632068.2
No. of Shares: 9682 (Approx)
Performance:-36.8%
P/L: ₹-367931.8
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
